CLINICAL_TRIALS
trial_result
· 2015-03-18
Clinical Trial Update: Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients [Phase 3]
Summary
Phase 3 study completed comparing sevelamer carbonate powder with sevelamer hydrochloride tablets in haemodialysis patients with chronic kidney disease to demon…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED